Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2025-12-24 @ 4:19 PM
Study NCT ID:
NCT04296266
Status:
COMPLETED
Last Update Posted:
2020-03-05
First Post:
2020-02-20
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery
Sponsor:
Stanford University
Organization:
Study Overview
Official Title:
Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is determine salivary gland disposition of d-limonene, the primary component in citrus peel and a common dietary supplement.
Salivary gland tissue and saliva will be collected to determine concentration of d-limonene and its metabolites in these tissues.
Salivary gland tissue and saliva will be collected to determine concentration of d-limonene and its metabolites in these tissues.
Detailed Description:
Primary Objective: To determine the bioavailability of Alda-341 in salivary gland tissue.
Secondary Objective: To determine the bioavailability of Alda-341 in saliva and blood
Secondary Objective: To determine the bioavailability of Alda-341 in saliva and blood
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: